NOS3 and atherosclerosis: Expectedly, administration of XMJ, as well as lovastatin and ZBT, reserved BH4 levels (Fig. 7A) and eNOS phosphorylations in carotid artery (Fig. 7B), and serum NO level (Fig. 7C) in rats with atherosclerosis.